Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
You can also access detailed information by clicking Login in the website header.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
Germany
Regulatory Approval:
Your Trustedworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Foscavir (foscarnet sodium) is an antiviral medication used to treat serious viral infections in immunocompromised patients, particularly when other antivirals are not effective.
Foscavir is FDA-approved for immunocompromised patients with cytomegalovirus (CMV) retinitis, and for mucocutaneous herpes simplex virus (HSV) infections that are resistant to acyclovir.
Foscarnet directly inhibits viral DNA polymerase without requiring activation by viral thymidine kinase, which is why it remains effective against acyclovir-resistant HSV strains that have altered thymidine kinase activity.
For CMV retinitis, induction treatment is typically 60 mg/kg every 8 hours for 2-3 weeks, followed by maintenance dosing of 90-120 mg/kg once daily. Foscavir must be administered by controlled intravenous infusion using an infusion pump — never by rapid or bolus injection — as determined by the treating physician based on renal function.
Boxed Warning — Foscavir: Foscavir must never be administered by rapid or bolus intravenous injection — toxicity may be increased due to excessive plasma levels. An infusion pump must be used to carefully control the infusion rate. Foscavir is associated with significant renal impairment, and dosage must be adjusted based on creatinine clearance, with careful monitoring of renal function throughout treatment.
Renal impairment is common. Monitor serum creatinine and creatinine clearance before treatment, several times per week during induction, and periodically during maintenance therapy. Adequate hydration helps reduce this risk.
Foscarnet can cause abnormalities in calcium, phosphate, magnesium, and potassium. Monitor electrolytes regularly.
Associated with electrolyte disturbances. Monitor for seizure activity, particularly in patients with renal impairment or electrolyte abnormalities.
Irritation of genital mucosa can occur due to high foscarnet concentrations in urine; maintaining good hydration reduces this risk.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
Foscavir (foscarnet sodium) is manufactured by Clinigen Healthcare, used for serious CMV and acyclovir-resistant HSV infections in immunocompromised patients.
Import of Foscavir through a Named Patient Program requires a valid prescription from the treating specialist, confirmation of diagnosis and renal function status, and supporting clinical documentation as required by Indian regulatory authorities.
NPP sources Foscavir directly from Clinigen Healthcare's authorized supply chain to ensure product authenticity and regulatory compliance.
Foscavir is sourced through verified, GDP-compliant channels from Clinigen Healthcare's authorized supply chain to ensure authenticity and quality.
Foscavir should be stored at 20°C to 25°C (68°F to 77°F). Do not refrigerate or freeze, as this can cause precipitation.
Once sourced, Foscavir is packed and transported under appropriate temperature-controlled conditions to preserve product integrity throughout the import process, with tracking and updates provided at each stage of delivery to the patient or treating hospital in India.
Patients across India can access Foscavir through NPP's regulated import pathway, with infectious disease specialists in major cities supporting the treatment process.
Leading infectious disease centers in Mumbai support treatment coordination for Foscavir access.
Delhi's major hospitals assist patients with prescription support and documentation for Foscavir.
Bangalore's specialist network offers access to Foscavir for eligible immunocompromised patients.
Chennai-based specialists coordinate Foscavir access alongside comprehensive infection management.
Hyderabad's care institutions support patients pursuing Foscavir therapy.
Kolkata's specialist centers help coordinate documentation and treatment access for Foscavir.
Pune-based specialists assist with treatment planning for Foscavir.
Ahmedabad's specialty hospitals support the import and treatment process for Foscavir.
Kochi's specialist units assist patients with the documentation needed for Foscavir access.
Chandigarh's care centers support Foscavir treatment coordination for patients from North India.
Jaipur's specialists help patients navigate the Foscavir access process.
Lucknow-based centers assist patients pursuing Foscavir therapy.
Bhubaneswar's institutions support access to Foscavir for eligible patients.
Guwahati's specialists help coordinate Foscavir access for patients across the Northeast.
Patients in other cities across India can also access Foscavir through NPP's nationwide coordination network.
Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 10 September 2026
Sources: FDA • CDSCO
Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 10 September 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
